Stock listing

SLXN Stock Price, News, Filings & Events — Silexion Therapeutics Corp

Selected listing: SLXN · NASDAQ · USD · US

This page tracks Silexion Therapeutics Corp's SLXN:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following SLXN:NASDAQ. SLXN:NASDAQ is the stock-level entry point for investors researching Silexion Therapeutics Corp, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Silexion Therapeutics Corp, trading under the ticker SLXN, is a public company based in America with a market capitalization of approximately $2.41 million. The company focuses on developing innovative therapeutic solutions. Investors can find relevant information about Silexion's operations and market performance on its dedicated public company page.

SLXN:NASDAQUSDUSUpdated September 11, 2026
Silexion Therapeutics Corp logo
Ticker
SLXN:NASDAQ
Asset type
Stock
Market cap
$2.1M
Sector
Health Technology
Industry
Pharmaceuticals: Major
Exchange
NASDAQ
Currency
USD

Silexion Therapeutics Corp SLXN:NASDAQ stock context

This page tracks Silexion Therapeutics Corp's SLXN:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following SLXN:NASDAQ. SLXN:NASDAQ is the stock-level entry point for investors researching Silexion Therapeutics Corp, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Silexion Therapeutics Corp, trading under the ticker SLXN, is a public company based in America with a market capitalization of approximately $2.41 million. The company focuses on developing innovative therapeutic solutions. Investors can find relevant information about Silexion's operations and market performance on its dedicated public company page.

Latest news from Silexion Therapeutics Corp

All Silexion Therapeutics Corp news →

Research Silexion Therapeutics Corp

Alternate listings